Su Wang
Beihang University
7 Papers
Su Wang is an academic researcher from Beihang University. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 1 publications. Previous affiliations of Su Wang include Beijing University of Civil Engineering and Architecture.
Chat about Author
Papers
Research of three-dimensional force sensor based on multiplexed fiber Bragg grating strain sensors
TL;DR: A 3-D force sensor based on multiplexed FBG strain sensors is proposed, which can be used to measure 3- D force on a structure under test, force distribution, and the trend of relative microdeformation.
12
EP08.01-096 Lung Immune Prognostic Index is Prognostic in Patients Treated with PD-1 Inhibitor Combined with Chemotherapy for Non-small Cell Lung Cancer
TL;DR: In this article , the authors investigated the relationship between LIPI and treatment outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors (ICIs) plus chemotherapy.
599P Tumor mutation burden is a predictive biomarker for survival to patients with ovarian carcinoma
TL;DR: In this paper , the authors explored the prognostic role of TMB in ovarian cancer by public databases and found that TMB was a significant predictor of DFS and patients with non-TMB-H had worse DFS with Hazard Ratio of 1.850.
Stem cell mobilization and autologous stem cell transplantation after bendamustine, prednisone and bortezomib induction in multiple myeloma patients with renal impairment
Stephan Fricke,Su Wang,T. Holzhey,Madlen Holzvogt,Marc Andrea,Vladan Vucinic,Georg-Nikolaus Franke,Simone Heyn,Saskia Hell,B. Schetschorke,Madlen Jentzsch,Sebastian Schwind,Thomas Zehrfeld,Leanthe Braunert,Thomas Edelmann,Cornelia Becker,F. Hoffmann,Kolja Reifenrath,M Schwarz,Andreas Schwarzer,Franziska Flade,D. Hammerschmidt,Markus Scholz,Maximilian Merz,Uwe Platzbecker,Wolfram Pönisch +25 more
TL;DR: In this article , the authors analyzed the efficacy of a BPV induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (MM) patients depending on the severity of renal impairment.
350P Primary prevention of chemotherapy-induced neutropenia in patients with advanced lung cancer in real-world research
TL;DR: In this paper , Neutropenia is a major dose-limiting toxicity of myelosuppressive chemotherapy and has been commonly found in lung cancer patients treated with platinum-based chemotherapy.